The four-week minimum exists because shorter intervals typically lead to worse side effects without improving long-term outcomes
Most health insurance carriers will cover tirzepatide for weight loss for people who are obese or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol
This is all part of giving customers more ways to start and help sustain their health journey based on their unique history, preferences, needs, and goals
In contrast to CFU-e, BFU-e progenitors proliferate slowly [36] and respond to stem cell factor (SCF), interleukin-3 (IL-3), IL-6, and insulin-like growth factor 1 (IGF-1) [36,37,38]